Search all trials

Find therapies in clinical trials near you – page 7

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Prostate cancer+2

Not recruiting

Registered drug

Study on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

Study Comparing Degarelix and Drug Combination with Radiotherapy for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Degarelix

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

Study on Darolutamide with Radiation Therapy for Patients with Intermediate Unfavorable Risk Prostate Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Prostate cancer

Not recruiting

InvestigationalNo placebo

Study of Florastamin (18F) PET/CT Imaging for Detection of Significant Prostate Cancer in Patients with Elevated PSA Levels and Unclear MRI Results

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:(9S,13S)-1-(1-(2-(2-(2-[18F]Fluoroethoxy)Ethoxy)Ethyl)-1H-1,2,3-Triazol-4-Yl)-3,11-Dioxo-2,4,10,12-Tetraazapentadecane-9,13,15-Tricarboxylicacid

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

Study on Enzalutamide and Talazoparib for Treating Metastatic Hormone-Naïve Prostate Cancer in Patients

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

Study on Hormonal Treatment with Leuprorelin Acetate for Prostate Cancer Patients at High Risk of Recurrence After Surgery

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Leuprorelin Acetate

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

Study on Enzalutamide for Patients with Localized Prostate Cancer Undergoing Robotic-Assisted Surgery

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Prostate cancer

Not recruiting

InvestigationalNo placebo

Study of Apalutamide for Patients with High-Risk Prostate Cancer After Prostate Removal

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

Study on Enzalutamide and Drug Combination for High-Risk Localized Prostate Cancer Patients

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Bicalutamide

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and 68GA-PSMA HBED-CC in Patients with High-Risk Prostate Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

A Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cabazitaxel

Contact Research Centre

Prostate cancer

Not recruiting

InvestigationalNo placebo

Study on Imaging-Guided Surgery for Prostate Cancer Patients Using [68Ga]PSMA-HBED-CC and [99mTc]PSMA I&S

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:[99MTC]PSMA I&S

Contact Research Centre

Find therapies in clinical trials near you – page 7

101 trials match your criteria

Prostate cancer+2

Study on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients

Prostate cancer

Study Comparing Degarelix and Drug Combination with Radiotherapy for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Prostate cancer

Study on Darolutamide with Radiation Therapy for Patients with Intermediate Unfavorable Risk Prostate Cancer

Prostate cancer

Study of Florastamin (18F) PET/CT Imaging for Detection of Significant Prostate Cancer in Patients with Elevated PSA Levels and Unclear MRI Results

Prostate cancer

Study on Enzalutamide and Talazoparib for Treating Metastatic Hormone-Naïve Prostate Cancer in Patients

Prostate cancer

Study on Hormonal Treatment with Leuprorelin Acetate for Prostate Cancer Patients at High Risk of Recurrence After Surgery

Prostate cancer

Study on Enzalutamide for Patients with Localized Prostate Cancer Undergoing Robotic-Assisted Surgery

Prostate cancer

Study of Apalutamide for Patients with High-Risk Prostate Cancer After Prostate Removal

Prostate cancer

Study on Enzalutamide and Drug Combination for High-Risk Localized Prostate Cancer Patients

Prostate cancer

Study of Pembrolizumab and 68GA-PSMA HBED-CC in Patients with High-Risk Prostate Cancer

Prostate cancer

A Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer

Prostate cancer

Study on Imaging-Guided Surgery for Prostate Cancer Patients Using [68Ga]PSMA-HBED-CC and [99mTc]PSMA I&S

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.